The FDA has granted accelerated approval to AstraZeneca drug Etcamah for certain adults with advanced breast cancer carrying an ESR1 mutation. Etcamah, also known as camizestrant,...
A French court has linked cosmic radiation to a former flight attendant’s breast cancer for the first time. Sophie Lainault, 59, had sought to have her...
A drug targeting a key regulator in triple-negative breast cancer reduced tumour growth and cancer stem cell viability in laboratory models. Triple-negative breast cancer is an...
Australia’s drug advisory committee has recommended wider funding of triptorelin for women with breast cancer or endometriosis. The recommendation comes after AstraZeneca announced plans to remove...
An AI tool has identified microscopic breast cancer patterns that could help medical professionals better forecast disease progression. The tool, called CenSegNet, was developed to analyse...
Glaucoma drugs could potentially be repurposed to treat aggressive breast cancer after researchers identified markers linked to response. Scientists found that several cancers, including breast cancer,...
Weekly app monitoring can reduce fatigue and improve daily life for women with metastatic breast cancer, according to a study. The approach involves regularly asking patients...
The Welsh Government has been urged to invest in breast cancer services after figures showed continuing delays in diagnosis and treatment. Breast Cancer Now said the...
Contrast-enhanced mammography (CEM) has shown promise for women at higher risk of breast cancer, with follow-up screening showing greater specificity and accuracy. Cancer detection rates remained...
AstraZeneca’s breast cancer drug Etcamah has been approved in the EU as part of a combination treatment for advanced disease. The European Commission acted on a...
